Sulfasalazine and Exforge drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Sulfasalazine (sulfasalazine) and Exforge (amlodipine besylate; valsartan). Common drug interactions include pallor among females and ankylosing spondylitis among males.
The phase IV clinical study analyzes what interactions people have when they take Sulfasalazine and Exforge. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.
What is Sulfasalazine?
Sulfasalazine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 96,787 Sulfasalazine users. Check the latest studies of Sulfasalazine.
What is Exforge?
Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.
30 people who take Sulfasalazine and Exforge together, and have interactions are studied.

What are the common drug interactions of Sulfasalazine and Exforge, by gender? *:
female:
- Pallor
- Pulmonary mass
- Red blood cell sedimentation rate increased
- Respiratory disorder (respiratory disease)
- Rheumatoid factor increased
- Skin plaque (red, scaly patches to appear on the skin)
- Therapeutic response decreased (less preventive response)
- Tooth extraction
- Vomiting
- Diarrhoea
male:
- Ankylosing spondylitis (type of arthritis affecting the spine)
- Diarrhoea
- Arthralgia (joint pain)
- Bacterial infection
- Burning sensation
- Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
- Colitis ulcerative (inflammation of colon with ulcer)
- Comminuted fracture (bone has broken into several pieces)
- Constipation
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
What are the common drug interactions of Sulfasalazine and Exforge, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Arthralgia (joint pain)
- Comminuted fracture (bone has broken into several pieces)
- Hydronephrosis (water inside the kidney)
- Joint swelling
- Nephrolithiasis (calculi in the kidneys)
- Pyrexia (fever)
- Wound infection
40-49:
- Sudden hearing loss
- Arthralgia (joint pain)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Diarrhoea
- Eating disorder
- Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
- Migraine (headache)
- Nephrolithiasis (calculi in the kidneys)
- Pallor
- Respiratory disorder (respiratory disease)
50-59:
- Pyrexia (fever)
- Rectal ulcer (ulcer of rectum)
- Sensation of foreign body
- Stomatitis (inflammation of mucous membrane of mouth)
- Type iv hypersensitivity reaction (delayed type hypersensitivity as the reaction takes two to three days to develop)
- Upper respiratory fungal infection
- Arthropathy
- Bacterial infection
- Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
- Nephrolithiasis (calculi in the kidneys)
60+:
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Gamma-glutamyltransferase increased
- Glomerular filtration rate decreased
- Glycosylated haemoglobin increased
- Hepatic failure (liver failure)
- Intervertebral disc protrusion (spinal disc protrusion)
- Leukopenia (less number of white blood cells in blood)
- Malignant neoplasm progression (cancer tumour came back)
- Menopausal symptoms
What are the existing conditions these people have? *
- High Blood Pressure: 16 people, 53.33%
- High Blood Cholesterol: 6 people, 20.00%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 5 people, 16.67%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 10.00%
- Pain: 3 people, 10.00%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 10.00%
- Diabetes: 3 people, 10.00%
- Diarrhea: 2 people, 6.67%
- Arrhythmias (irregular heartbeat): 2 people, 6.67%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Sulfasalazine and Exforge?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Sulfasalazine (96,787 reports)
- Exforge (13,350 reports)
Browse all drug interactions of Sulfasalazine and Exforge:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sulfasalazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Exforge:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sulfasalazine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Exforge and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on sulfasalazine and amlodipine besylate; valsartan (the active ingredients of Sulfasalazine and Exforge, respectively), and Sulfasalazine and Exforge (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Dilantin and Eprex - 8 seconds ago
- Demerol vs. Adderall, side effect and effectiveness comparison - 45 seconds ago
- Coreg vs. Amvaz, side effect and effectiveness comparison - a minute ago
- Malaise and Heart Palpitations - a minute ago
- Could Dapsone cause Abdominal Abscess? - 2 minutes ago
- Could Fluoride cause Ankylosing Spondylitis? - 2 minutes ago
- Drug interactions of Ketoconazole and Cordran - 2 minutes ago
- Drug interactions of Avodart and Lovastatin - 3 minutes ago
- Could Gabapentin cause Vaginal Infection? - 3 minutes ago
- Could Letairis cause Swelling? - 3 minutes ago